Delcath Systems Inc Sustainability Reports
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company develops and commercializes targeted liver-directed chemotherapy delivery systems.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300NVPLITUM6URT02
FIGI: BBG001S81551
4 reports from 2007 to 2023
